力大圖書
力 大 醫 學 圖 書 網          www.leaderbook.com.tw          歡迎使用  國民旅遊卡!!
帳號 密碼
加入會員 | 首頁 | 服務 | 行銷回應 | 代訂 | 購物車 | 預訂清單
  
Search
      圖書搜尋

 - 進階搜尋
  代訂書籍
  加購書籍專區
Classes
      圖書類別
藝FUN券使用須知
國民旅遊卡使用須知
購買注意事項
力大中文圖書
橘井文化系列叢書
免疫風濕科
內分泌科
內科(家醫科及實証醫學)
婦產科
眼科
病理科(檢驗科)
外科
耳鼻喉科(聽力和語言治療)
泌尿科
胸腔內科(重症醫學)
胸腔外科
腫瘤科(血液科)
放射腫瘤科
麻醉科(疼痛科)
獸醫科
神經外科
神經內科
小兒科
心臟內科
心臟外科
急診科
感染科
放射線科
核子醫科
牙科(口腔外科)
皮膚科(醫學美容)
精神科
胃腸科
骨科
腎臟科
整形外科
藥劑科
護理科
復健科(運動醫學)
食品營養
限量特價專區
SPRINGER庫存出清專區
解剖學(組織學)
基礎醫學科
醫學系列書籍
醫學模型
醫學掛圖
 
 
 
-■ ■ ■ ■ ■ ■ 圖 書 介 紹
Stroke Prevention
-神經內科
- 編號: 019513382x
- 作者:John W. Norris
- 原價-3050    - (熱賣價)2750      - 節省 ↓10%
- 加入購物車
推薦指數:
- 內容介紹
Stroke Prevention
by John W. Norris (Editor), Vladimir Hachinski (Editor)

Hardcover (March 2001)
Oxford University Press; ISBN: 019513382X

Editorial Reviews
From the New England Journal of Medicine, January 17, 2002
Stroke is the third leading cause of death in the United States and has resulted in disability in more than 4 million survivors of stroke. The economic burden of the approximately 700,000 new strokes annually is $20 billion to $40 billion in direct and indirect costs. Yet few books deal with the prevention of stroke. For this reason, Stroke Prevention is a timely and outstanding resource.
Having edited a book on this topic a decade ago (Prevention of Stroke. New York: Springer-Verlag, 1991), Norris and Hachinski, who are recognized experts in the field of cerebrovascular disease, set out to bring the book up to date with respect to advances in stroke prevention from an international perspective. In particular, they wished to focus on newly identified risk factors for stroke and new therapeutic approaches. Although its emphasis is not explicitly stated, this book deals almost exclusively with ischemic stroke, which accounts for approximately 80 percent of all strokes. Multiple authors, selected for their expertise in a particular area, contributed to the individual chapters. The quality of the writing and of the information provided is exceptional, despite an occasional one-sided view of a controversial subject. The authors, who have spent their careers performing clinical trials in stroke prevention and lecturing on these topics, provide a novel perspective on the evolution of efforts in stroke prevention over the decades. The inclusion of authors from outside the United States provides a global dimension to discussions of the issues confronted in stroke prevention, which are emphasized in the final chapters of the book.

The book has three sections: ``Primary Prevention,'' ``Secondary Prevention,'' and ``Prevention: Policy and Practice.'' The distinction between primary and secondary prevention can be problematic. Why should the management of atrial fibrillation be considered primary prevention, whereas the management of patent foramen ovale or a prosthetic valve is designated secondary prevention? Since all the conventional vascular risk factors are discussed in the section on primary prevention, the notion that there may be different goals for secondary prevention is not broached. Secondary prevention is defined by the editors as prevention after patients have had a transient ischemic attack or a stroke, and although this is a conventional definition, it is clear that cerebrovascular disease may begin well before symptoms appear. Research in defining preclinical disease with biologic or genetic markers to effect early intervention is on the forefront of stroke-prevention efforts.

The inclusion of a section dealing with the implementation of the results of clinical trials and the economics of stroke prevention is laudable. These subjects are rarely raised in treatises on stroke prevention, but they are of critical importance. In chapters dealing with clinical epidemiology and trial design, there are useful tables defining and summarizing terminology that may be unfamiliar to some readers, such as the measures used to assess the results of screening tests, the classification of diagnostic recommendations on the basis of the strength of the scientific evidence, and the phases of clinical trials.

This book comes at an important crossroads in terms of clinical trials in stroke prevention. Issues regarding carotid endarterectomy for symptomatic carotid stenosis and the medical management of atrial fibrillation have largely been resolved. The statins have emerged as a new class of stroke-prevention agents. There are ongoing studies exploring carotid stenting, indications for the use of warfarin, and the treatment of hyperhomocysteinemia; in the future, one hopes there will be trials to assess the effects of lifestyle and dietary modification.

It is important to recognize that the major strength of this book is its comprehensive review of epidemiologic studies and clinical trials in the area of stroke prevention. The reference lists are uniformly exhaustive and current. It is less useful as a practical, handbook-style clinical guide, and several chapters cite consensus guidelines for those seeking such information.

This book establishes the state of the art for stroke prevention and provides a vision of the research necessary to further stroke-prevention efforts in the coming years. Since the publication of this book, several new studies of the effects of antihypertensive therapy, estrogens, and antithrombotic therapy on the risk of stroke have already emerged. This is a rapidly evolving field of science, one that warrants this type of routine comprehensive updating.

Karen Furie, M.D., M.P.H.
Copyright © 2002 Massachusetts Medical Society. All rights reserved. The New England Journal of Medicine is a registered trademark of the MMS.


Book Info
Univ. of Toronto, Ontario, Canada. A guide to the treatment of stroke, providing a comprehensive, critical review of the primary and secondary prevention of the disease, with translation into clinical practice. Offers clinicians outlines of risk factors, and coverage of the protective effects of lifestyle changes, diet, exercises, and other healthful practices.



歡迎使用國民旅遊卡
歡迎使用國民旅遊卡
其他相關書藉
  請輸入關鍵字
相 關 書 藉
Stroke: Pathophysiology, Diagnosis, and Management, 6/E 2016
- 神經內科
- 作者:James C. Grotta MD
Differential Diagnosis in Neurology
- 神經內科
- 作者:Sudesh, M.D. Prabhakar
Neuroinflammation: New Insights into Beneficial and Detrimental Functions 2015
- 神經內科
- 作者:Samuel David
Regional Nerve Blocks & Infiltration Therapy
- 神經內科
- 作者:Jankovic, Danilo
Electromyography in Clinical Practice: A Case Study Approach 2nd Edition 2007(限量特價)
- 神經內科
- 作者: Bashar Katirji MD FACP
--- more
[ 積點系統 ]
您已經累積多少點數您知道嗎?別忘了登錄會員,察看您的點數,獎品就等您來拿喲!
[ 訂購辦法 ]
您還不知道要在本網站如何購物嗎?我們將會提供給您訂購的方法及購物相關資訊喲!讓您彈指間取得想要的書藉。
 
      圖書搜尋         本網站購物機制使用 SSL+ 加密技術,請放心購物 Safe100%

| 加入會員 | 回首頁 | 服務中心 | 行銷回應 | 購物須知 | 會員條款 | 關於力大 | 權益申明 | 合作對象 |

本站內容為 力大圖書有限公司 所有,未經同意,請勿任意引用轉載
電話:(02)2733-2592 傳真:(02)2732-5743 E-mail:service@leaderbook.com.tw
力大圖書:台北市和平東路二段90巷2號4樓之2  台中分店:臺中榮總婦幼大樓1F
Copyright 2002-2010 LeaderBook CO.,LTD All rights reserved.